Central Retinal Vein Occlusion (CRVO)
1 clinical trials · Condition
◉ Watch Central Retinal Vein Occlusion (CRVO)
| Record | Firm | Date |
|---|---|---|
| Evaluation of Physician Knowledge of Safety and Safe Use Information for Aflibercept in Canada (NCT02585401) | Bayer | 2016-02-18 |
Track Central Retinal Vein Occlusion (CRVO) automatically
Every clearance here is in the API, with alerts when new ones post.